Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “lung cancer”

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid TumorsNot Yet Recruiting
NCT07807956Phase 1Updated Sep 8, 2026
Sponsor: AbbVie
Advanced Solid Tumors · Non-Small Cell Lung Cancer · Colorectal Cancer · Pancreatic Ductal Adenocarcinoma
A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor MutationsActive Not Recruiting
NCT05801029Phase 2Updated Sep 8, 2026
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer (NSCLC)
Hong Kong, Malaysia, Singapore, South Korea, Taiwan +1 more
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)Completed
NCT05153239Phase 3Updated Sep 8, 2026
Sponsor: PharmaMar
Relapsed Small Cell Lung Cancer
United States, Australia, Austria, Belgium, Brazil +19 more
Evaluation for NCI Surgery Branch Clinical Research ProtocolsRecruiting
NCT00001823N/AUpdated Sep 8, 2026
Sponsor: National Cancer Institute (NCI)
Synovial Cell Cancer · Melanoma · Colorectal Cancer · Lung Cancer
United States
Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLCRecruiting
NCT07718243Phase 1, Phase 2Updated Sep 8, 2026
Sponsor: Institute of Cancer Research, United Kingdom
Melanoma (Skin Cancer) · Non Small Cell Lung Cancer · Solid Tumor in Advanced Stage
United Kingdom
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT06568939Phase 2Updated Sep 8, 2026
Sponsor: AbbVie
Non-Small Cell Lung Cancer
United States, Brazil, China, Israel, Japan +2 more
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)Recruiting
NCT06345729Phase 3Updated Sep 8, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Brazil +22 more
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung CancerActive Not Recruiting
NCT04092283Phase 3Updated Sep 8, 2026
Sponsor: National Cancer Institute (NCI)
Recurrent Lung Non-Small Cell Carcinoma · Stage III Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8 · Stage IIIB Lung Cancer AJCC v8
United States, Guam
Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin ReductionRecruiting
NCT07132190Phase 2Updated Sep 8, 2026
Sponsor: Ayal A. Aizer, MD
Brain Metastases, Adult · Brain Tumor - Metastatic · Brain Metastases From Non-small Cell Lung Cancer (NSCLC) · Brain Metastases From Extra-cranial Solid Tumors
United States
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung CancerRecruiting
NCT06712316Phase 2, Phase 3Updated Sep 4, 2026
Sponsor: BioNTech SE
Non-small Cell Lung Cancer
United States, Australia, Belgium, Brazil, Bulgaria +15 more
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR TrialSuspended
NCT04402788Phase 2, Phase 3Updated Sep 4, 2026
Sponsor: National Cancer Institute (NCI)
Extensive Stage Lung Small Cell Carcinoma
United States
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)Recruiting
NCT07144280Phase 3Updated Sep 4, 2026
Sponsor: Pfizer
Non-small Cell Carcinoma · Non-Small Cell Lung Cancer Metastatic · Non-Small Cell Lung Carcinoma
United States, Argentina, Australia, Belgium, Brazil +24 more
A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid MalignanciesRecruiting
NCT07613723Phase 1Updated Sep 4, 2026
Sponsor: Zelluna Immunotherapy AS
Ovarian Cancer · Squamous Non-Small Cell Lung Cancer (NSCLC) · Synovial Sarcomas · Head and Neck Cancer
United Kingdom
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic AlterationsRecruiting
NCT07291037Phase 3Updated Sep 4, 2026
Sponsor: AstraZeneca
Non-small Cell Lung Cancer (NSCLC)
United States, Australia, Austria, Belgium, Brazil +16 more
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)Recruiting
NCT07218146Phase 3Updated Sep 4, 2026
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Small-cell Lung Cancer
United States, Austria, Belgium, China, Czechia +10 more
Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung CancerNot Yet Recruiting
NCT07640932Phase 2Updated Sep 4, 2026
Sponsor: Yonsei University
Carcinoma, Small Cell Lung
South Korea
Phase 1 Study of PF-08046033 in Advanced Solid TumorsRecruiting
NCT07519655Phase 1Updated Sep 4, 2026
Sponsor: Pfizer
Non-Small-Cell Lung · Esophageal Cancer · Cutaneous Melanoma
United States, Puerto Rico, South Korea
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C MutationRecruiting
NCT07012031Phase 1, Phase 2Updated Sep 4, 2026
Sponsor: National Cancer Institute (NCI)
Locally Advanced Lung Non-Small Cell Carcinoma · Metastatic Lung Non-Small Cell Carcinoma · Stage III Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8
United States
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsRecruiting
NCT07090499Phase 1Updated Sep 4, 2026
Sponsor: Pfizer
Advanced/Metastatic Solid Tumors · Bladder Cancer · Urothelial Carcinoma · Advanced Non-Small Cell Lung Cancer
United States, Canada, China, Puerto Rico, Spain +1 more
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT06236438Phase 2, Phase 3Updated Sep 4, 2026
Sponsor: AbbVie
Non-Small Cell Lung Cancer
United States, Australia, Belgium, Chile, France +7 more
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialRecruiting
NCT06096844Phase 3Updated Sep 4, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Lung Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Stage IIIC Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8
United States
A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)Recruiting
NCT07298096NAUpdated Sep 4, 2026
Sponsor: M.D. Anderson Cancer Center
Cancer
United States
The Prospective Non-randomized Case-control Study From Real-world Lung Cancer PatientsCompleted
NCT04909164N/AUpdated Sep 4, 2026
Sponsor: Myung-Ju Ahn
Non-small Cell Lung Cancer (NSCLC)
South Korea
Study to Confirm Efficacy and Feasibility of Tarlatamab Treatment in Patients With Extensive Stage Small-cell Lung Cancer With Poor Performance StatusRecruiting
NCT07803848Phase 2Updated Sep 4, 2026
Sponsor: AIO-Studien-gGmbH
Small-cell Lung Cancer
Germany
ProSight: A Multi-centre Interventional Study Evaluating MCED in Asymptomatic PopulationCompleted
NCT06790355NAUpdated Sep 4, 2026
Sponsor: Shanghai Weihe Medical Laboratory Co., Ltd.
Lung Cancer · Colorectal Cancer · Liver Cancer · Grastic Cancer
China

Previous page Next page